Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05161897 · ClinicalTrials.gov registry record · NA
Individualized Nutrition Therapy for Preventing or Delaying Onset of Type-2 Diabetes
A NA study, sponsored by George Mason University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT05161897 is a NA study that has completed, run by George Mason University. The registered enrollment target is 30 participants.
The verdict
NCT05161897, a NA study, has completed, sponsored by George Mason University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The overall aim of this feasibility study is to conduct a randomized, controlled intervention providing adults with prediabetes either an individualized nutrition therapy (INT) intervention that contains individualized dietary goal-setting components, the goal being to improve blood glucose, reduce CVD risk factors, and therefore postpone the onset of diabetes and related cardiovascular disease, or standard-of-care generalized dietary recommendation (SOC). The hypothesis is that the INT arm will experience greater benefits in some or all of the following primary outcome variables: improvement in postprandial blood glucose, oral glucose tolerance test, fasting insulin, and calculated insulin sensitivity (HOMA) in individuals with prediabetes. Secondary outcome variables are improved markers of inflammation, antioxidant status, blood lipids, blood pressure, and endothelial function.
Interventions
- OTHER Individualized Nutrition Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-08-25 |
| Est. Completion | 2023-12-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05161897
The ClinicalTrials.gov registry entry for NCT05161897 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Mason University, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Individualized Nutrition Therapy is the first listed.
NCT05161897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05161897 about?
NCT05161897 is a clinical study titled "Individualized Nutrition Therapy for Preventing or Delaying Onset of Type-2 Diabetes". The overall aim of this feasibility study is to conduct a randomized, controlled intervention providing adults with prediabetes either an individualized nutrition therapy (INT) intervention that contains individualized dietary goal-setting components, the goal being to improve blood glucose, reduce ...
What is the current status of trial NCT05161897?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-08-25. Estimated completion is 2023-12-14.
What interventions are being tested in trial NCT05161897?
The interventions under investigation include: Individualized Nutrition Therapy (OTHER).
Who is sponsoring clinical trial NCT05161897?
This trial is sponsored by George Mason University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.